Clinical characteristics and management outcome of acute infectious endophthalmitis.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
03 Jul 2024
Historique:
received: 29 04 2024
accepted: 26 06 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: epublish

Résumé

This study aimed to investigate the demographics, clinical characteristics, and management outcomes of patients with acute infectious endophthalmitis (AIE). This retrospective chart review was conducted on all patients admitted with the clinical diagnosis of infectious endophthalmitis from 2017 to 2022. Demographic data, patients' clinical characteristics, the type of acute infectious endophthalmitis (post-operative, post-traumatic, bleb-associated, and endogenous endophthalmitis), the type of surgical procedure in the post-operative cases, the microbiologic analysis results of vitreous samples, therapeutic measures, and visual outcomes of patients were recorded. In this study, 182 participants, including 122 male (67%) and 60 (33%) female, were involved. The mean age of patients was 54.56 ± 21 years, with a range of 1-88 years old. The most prevalent type of AIE was post-operative (59.9%), followed by endogenous (19.2%), post-traumatic (17%), and bleb-associated (3.8%). The most common type of intraocular surgery in the post-operative subgroups of AIE patients was phacoemulsification (57.8%). The median (interquartile range) of the primary and final BCVA of patients was 1.5 (1.35, 1.85) and 0.65 (0.35, 1.35), respectively. Vitreous haziness grade (OR, 2.89; 95% CI, 1.11-5.74; p = 0.009) and the primary VA (OR, 60.34; 95% CI, 2.87-126.8; p = 0.008) revealed statistical significance for final vision loss. AIE is a devastating condition with poor visual outcomes, which presents with acute inflammatory signs and symptoms regardless of its type. However, prompt and appropriate treatment leads to visual recovery to a functional level in many patients.

Identifiants

pubmed: 38958789
doi: 10.1007/s10792-024-03239-x
pii: 10.1007/s10792-024-03239-x
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

308

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Fan JC, Niederer RL, Von Lany H, Polkinghorne PJ (2008) Infectious endophthalmitis: clinical features, management and visual outcomes. Clin Exp Ophthalmol 36(7):631–636
pubmed: 18983548 doi: 10.1111/j.1442-9071.2008.01813.x
Tranos P, Dervenis N, Vakalis AN, Asteriadis S, Stavrakas P, Konstas AG (2016) Current perspectives of prophylaxis and management of acute infective endophthalmitis. Adv Ther 33:727–746
pubmed: 26935830 doi: 10.1007/s12325-016-0307-8
Lee JJ, Jo YJ, Lee JS (2022) Clinical characteristics and risk factors for visual prognosis according to the types of infectious endophthalmitis. PLoS One 17(12):e0278625
pubmed: 36454919 pmcid: 9714883 doi: 10.1371/journal.pone.0278625
Schwartz SG, Flynn HW Jr, Das T, Mieler WF (2016) Ocular infection: endophthalmitis. Retin Pharmacother 55:176–188
doi: 10.1159/000431195
Sheu S-J (2017) Endophthalmitis. Korean J Ophthalmol 31(4):283–289
pubmed: 28752698 pmcid: 5540982 doi: 10.3341/kjo.2017.0036
Vitrectomy E (1995) Results of the endophthalmitis vitrectomy study. Arch Ophthalmol 113:1479–1496
doi: 10.1001/archopht.1995.01100120009001
Min YG, Moon Y, Kwon YN, Lee BJ, Park K-A, Han JY et al (2024) Prognostic factors of first-onset optic neuritis based on diagnostic criteria and antibody status: a multicentre analysis of 427 eyes. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2023-333133
doi: 10.1136/jnnp-2023-333133 pubmed: 38777578
Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr (2015) Endophthalmitis: state of the art. Clin Ophthalmol. https://doi.org/10.2147/OPTH.S76406
doi: 10.2147/OPTH.S76406 pubmed: 25897196 pmcid: 4396511
Hatch WV, Cernat G, Wong D, Devenyi R, Bell CM (2009) Risk factors for acute endophthalmitis after cataract surgery: a population-based study. Ophthalmology 116(3):425–430
pubmed: 19091417 doi: 10.1016/j.ophtha.2008.09.039
Wong TY, Chee S-P (2004) The epidemiology of acute endophthalmitis after cataract surgery in an Asian population. Ophthalmology 111(4):699–705
pubmed: 15051201 doi: 10.1016/j.ophtha.2003.07.014
Yang X-B, Liu Y-Y, Huang Z-X, Mao Y, Zhao L, Xu Z-P (2018) Clinical analysis of 1593 patients with infectious endophthalmitis: a 12-year study at a tertiary referral center in Western China. Chin Med J 131(14):1658–1665
pubmed: 29998884 pmcid: 6048916 doi: 10.4103/0366-6999.235866
Lu X, Ng DS-C, Zheng K, Peng K, Jin C, Xia H et al (2016) Risk factors for endophthalmitis requiring evisceration or enucleation. Sci Rep 6(1):28100
pubmed: 27302573 pmcid: 4908388 doi: 10.1038/srep28100
Dehghani AR, Rezaei L, Salam H, Mohammadi Z, Mahboubi M (2014) Post traumatic endophthalmitis: incidence and risk factors. Glob J Health Sci 6(6):68–72
pubmed: 25363107 pmcid: 4825498 doi: 10.5539/gjhs.v6n6p68
Li X, Zarbin MA, Langer PD, Bhagat N (2018) Posttraumatic endophthalmitis: an 18-year case series. Retina 38(1):60–71
pubmed: 28590965 doi: 10.1097/IAE.0000000000001511
Dehghani AR, Rezaei L, Salam H, Mohammadi Z, Mahboubi M (2014) Post traumatic endophthalmitis: incidence and risk factors. Global J Health Sci 6(6):68
doi: 10.5539/gjhs.v6n6p68
Bhagat N, Nagori S, Zarbin M (2011) Post-traumatic infectious endophthalmitis. Survey Ophthalmol 56(3):214–251
doi: 10.1016/j.survophthal.2010.09.002
Asencio MA, Huertas M, Carranza R, Tenias JM, Celis J, Gonzalez-del VF (2016) A case–control study of post-traumatic endophthalmitis at a spanish hospital. Int Ophthalmol 36(2):185–194
pubmed: 26220873 doi: 10.1007/s10792-015-0099-x
Cunningham ET, Flynn HW, Relhan N, Zierhut M (2018) Endogenous endophthalmitis. Int Opthalmol 36:491–5
Sadiq MA, Hassan M, Agarwal A, Sarwar S, Toufeeq S, Soliman MK et al (2015) Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect 5(1):1–11
doi: 10.1186/s12348-015-0063-y
Peng K-L, Kung Y-H, Tsai H-S, Wu T-T (2021) Treatment outcomes of acute postoperative infectious endophthalmitis. BMC Ophthalmol 21(1):1–9
doi: 10.1186/s12886-021-02144-6
Sun J, Guo Z, Li H, Yang B, Wu X (2021) Acute infectious endophthalmitis after cataract surgery: epidemiological characteristics, risk factors and incidence trends, 2008–2019. Infect Drug Resist 14:1231–8
pubmed: 33790593 pmcid: 8007477 doi: 10.2147/IDR.S304675
Watanachai N, Choovuthayakorn J, Chokesuwattanaskul S, Photcharapongsakul C, Wongsirimeteekul P, Phinyo P et al (2021) Risk factors and outcomes of post-traumatic endophthalmitis: a retrospective single-center study. J Ophthalmic Inflamm Infect 11:1–9
doi: 10.1186/s12348-021-00254-2
Kohanim S, Daniels AB, Huynh N, Eliott D, Chodosh J (2012) Utility of ocular ultrasonography in diagnosing infectious endophthalmitis in patients with media opacities. Semin Ophthalmol 27:242–245
pubmed: 23163283 doi: 10.3109/08820538.2012.711417
Pijl BJ, Theelen T, Tilanus MA, Rentenaar R, Crama N (2010) Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. Am J Ophthalmol 149(3):482-487 e2
pubmed: 20053391 doi: 10.1016/j.ajo.2009.09.021
Fileta JB, Scott IU, Flynn HW Jr (2014) Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retin 45(2):143–149
doi: 10.3928/23258160-20140306-08
Westfall AC, Osborn A, Kuhl D, Benz MS, Mieler WF, Holz ER (2005) Acute endophthalmitis incidence: intravitreal triamcinolone. Arch Ophthalmol 123(8):1075–1077
pubmed: 16087840 doi: 10.1001/archopht.123.8.1075
Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y (2019) Incidence of endophthalmitis after vitrectomy: a systematic review and meta-analysis. Retina 39(5):844–852
pubmed: 29370034 doi: 10.1097/IAE.0000000000002055
Kunimoto DY, Kaiser RS, Service WER (2007) Incidence of endophthalmitis after 20-and 25-gauge vitrectomy. Ophthalmology 114(12):2133–2137
doi: 10.1016/j.ophtha.2007.08.009
Hosseini S, Daraee G, Shoeibi N, Bakhtiari E, Ansari-Astaneh M-R, Abrishami M et al (2022) Incidence rate and clinical characteristics of acute endophthalmitis following 23-gauge pars plana vitrectomy. Int J Retin Vitr 8(1):85
doi: 10.1186/s40942-022-00435-8
Keynan Y, Finkelman Y, Lagacé-Wiens P (2012) The microbiology of endophthalmitis: global trends and a local perspective. Eur J Clin Microbiol Infect Dis 31:2879–2886
pubmed: 22664925 doi: 10.1007/s10096-012-1659-x
Gentile RC, Shukla S, Shah M, Ritterband DC, Engelbert M, Davis A et al (2014) Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology 121(8):1634–1642
pubmed: 24702755 doi: 10.1016/j.ophtha.2014.02.001
Chakrabarti A, Shivaprakash MR, Singh R, Tarai B, George VK, Fomda BA et al (2008) Fungal endophthalmitis: fourteen years’ experience from a center in India. Retina 28(10):1400–7
pubmed: 19009680 doi: 10.1097/IAE.0b013e318185e943
Das T, Agarwal M, Behera U, Bhattacharjee H, Bhende M, Das AV et al (2020) Diagnosis and management of fungal endophthalmitis: India perspective. Expert Rev Ophthalmol 15(6):355–365
doi: 10.1080/17469899.2020.1820322
Bhoomibunchoo C, Ratanapakorn T, Sinawat S, Sanguansak T, Moontawee K, Yospaiboon Y (2013) Infectious endophthalmitis: review of 420 cases. Clin Ophthalmol. https://doi.org/10.2147/OPTH.S39934
doi: 10.2147/OPTH.S39934 pubmed: 23403798 pmcid: 3565585
Krause L, Bechrakis NE, Heimann H, Kildal D, Foerster MH (2009) Incidence and outcome of endophthalmitis over a 13-year period. Can J Ophthalmol 44(1):88–94
pubmed: 19169320 doi: 10.3129/i08-160
Lim HW, Shin JW, Cho HY, Kim HK, Kang SW, Song SJ et al (2014) Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina 34(3):592–602
pubmed: 24056527 doi: 10.1097/IAE.0b013e3182a2e705
Zhang H, Liu Z (2010) Endogenous endophthalmitis: a 10-year review of culture-positive cases in northern China. Ocul Immunol Inflamm 18(2):133–138
pubmed: 20370344 doi: 10.3109/09273940903494717
Connell P, O’neill E, Fabinyi D, Islam F, Buttery R, McCombe M et al (2011) Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye 25(1):66–72
pubmed: 20966972 doi: 10.1038/eye.2010.145
Shankar K, Gyanendra L, Hari S, Dev NS (2009) Culture proven endogenous bacterial endophthalmitis in apparently healthy individuals. Ocul Immunol Inflamm 17(6):396–399
pubmed: 20001259 doi: 10.3109/09273940903216891
Wong J-S, Chan T-K, Lee H-M, Chee S-P (2000) Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology 107(8):1483–1491
pubmed: 10919895 doi: 10.1016/S0161-6420(00)00216-5
Chen Y-J, Kuo H-K, Wu P-C, Kuo M-L, Tsai H-H, Liu C-C et al (2004) A 10-year comparison of endogenous endophthalmitis outcomes: an east Asian experience with Klebsiella pneumoniae infection. Retina 24(3):383–390
pubmed: 15187660 doi: 10.1097/00006982-200406000-00008
Chen K-J, Sun M-H, Chen Y-P, Wang N-K, Wu W-C, Lai C-C (2019) Endogenous endophthalmitis caused by infective endocarditis in East Asia. Ophthalmol Retin 3(4):382–384
doi: 10.1016/j.oret.2019.01.007
Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Murray TG, Berrocal A et al (2008) Endophthalmitis caused by Bacillus species. Am J Ophthalmol 145(5):883–888
pubmed: 18295182 doi: 10.1016/j.ajo.2007.12.026
Abu El-Asrar A, Al-Amro S, Al-Mosallam A, Al-Obeidan S (1999) Post-traumatic endophthalmitis: causative organisms and visual outcome. Eur J Ophthalmol 9(1):21–31
pubmed: 10230588 doi: 10.1177/112067219900900104
Gupta A, Srinivasan R, Kaliaperumal S, Saha I (2008) Post-traumatic fungal endophthalmitis—a prospective study. Eye 22(1):13–17
pubmed: 16751752 doi: 10.1038/sj.eye.6702463
Long C, Liu B, Xu C, Jing Y, Yuan Z, Lin X (2014) Causative organisms of post-traumatic endophthalmitis: a 20-year retrospective study. BMC Ophthalmol 14(1):1–7
doi: 10.1186/1471-2415-14-34
Bartz-Schmidt KU, Bermig J, Kirchhof B, Wiedemann P, Walter P, Heimann K (1996) Prognostic factors associated with the visual outcome after vitrectomy for endophthalmitis. Graefes Arch Clin Exp Ophthalmol 234:S51–S58
pubmed: 8871150 doi: 10.1007/BF02343048
Ness T, Pelz K, Hansen LL (2007) Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand 85(8):852–856
pubmed: 17725616 doi: 10.1111/j.1600-0420.2007.00982.x
de Lambert AC, Campolmi N, Cornut P-L, Aptel F, Creuzot-Garcher C, Chiquet C et al (2013) Baseline factors predictive of visual prognosis in acute postoperative bacterial endophthalmitis in patients undergoing cataract surgery. JAMA ophthalmol 131(9):1159–1166
doi: 10.1001/jamaophthalmol.2013.4242
Pappuru RR, Dave VP, Pathengay A, Gangakhedkar S, Sharma S, Narayanan R et al (2018) Endophthalmitis progressing to panophthalmitis: clinical features, demographic profile, and factors predicting outcome. Semin Ophthalmol 33:671–674
pubmed: 29256717 doi: 10.1080/08820538.2017.1416411

Auteurs

Mojtaba Abrishami (M)

Eye Research Center, Khatam Al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Gharani Boulevard, Mashhad, Iran.
Ocular Oncology Service, Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, Canada.

Majid Abrishami (M)

Eye Research Center, Khatam Al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Gharani Boulevard, Mashhad, Iran.

Nahid Hatami (N)

Eye Research Center, Khatam Al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Gharani Boulevard, Mashhad, Iran.

Nasser Shoeibi (N)

Eye Research Center, Khatam Al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Gharani Boulevard, Mashhad, Iran.

Seyedeh Maryam Hosseini (SM)

Eye Research Center, Khatam Al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Gharani Boulevard, Mashhad, Iran.

Mohammad Reza Ansari Astaneh (MR)

Eye Research Center, Khatam Al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Gharani Boulevard, Mashhad, Iran.

Elham Bakhtiari (E)

Eye Research Center, Khatam Al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Gharani Boulevard, Mashhad, Iran.

Mehrdad Motamed Shariati (M)

Eye Research Center, Khatam Al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Gharani Boulevard, Mashhad, Iran. mehrdad_shariati2005@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH